Circulating tumour cell clinical research collaboration announced between EKF Diagnos

[News]

EKF Diagnostics, the global diagnostics company, announces that it has entered into a two year research collaboration with Massachusetts General Hospital (MGH), a global leader in successfully bridging innovative science with state-of-the-art clinical medicine, to develop PointMan™ assays that can effectively detect treatable cancer mutations in blood samples.

More... (http://www.news-medical.net/news/20140923/Circulating-tumour-cell-clinical-research-collaboration-announced-between-EKF-Diagnostics-and-Massachusetts-General-Hospital.aspx)